#BEGIN_DRUGCARD DB03945

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
107-73-3

# ChEBI_ID:
18132

# Chemical_Formula:
C5H15NO4P

# Chemical_IUPAC_Name:
[2-(trimethylazaniumyl)ethoxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Phosphocholine

# HET_ID:
POC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1

# InChI_Key:
InChIKey=YHHSONZFOIEMCP-UHFFFAOYSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
C00588

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3945

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
184.1507

# Molecular_Weight_Mono:
184.073869485

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1H8P

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
4.36e+00 g/l

# Primary_Accession_No:
DB03945

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1014

# PubChem_Substance_ID:
46508785

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02629

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[N+](C)(C)CCOP(O)(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:47 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CRP

# Drug_Target_1_GenBank_ID_Gene:
M11880

# Drug_Target_1_GenBank_ID_Protein:
181066

# Drug_Target_1_GeneCard_ID:
CRP

# Drug_Target_1_Gene_Name:
CRP

# Drug_Target_1_Gene_Sequence:
>675 bp
ATGGAGAAGCTGTTGTGTTTCTTGGTCTTGACCAGCCTCTCTCATGCTTTTGGCCAGACA
GACATGTCGAGGAAGGCTTTTGTGTTTCCCAAAGAGTCGGATACTTCCTATGTATCCCTC
AAAGCACCGTTAACGAAGCCTCTCAAAGCCTTCACTGTGTGCCTCCACTTCTACACGGAA
CTGTCCTCGACCCGTGGGTACAGTATTTTCTCGTATGCCACCAAGAGACAAGACAATGAG
ATTCTCATATTTTGGTCTAAGGATATAGGATACAGTTTTACAGTGGGTGGGTCTGAAATA
TTATTCGAGGTTCCTGAAGTCACAGTAGCTCCAGTACACATTTGTACAAGCTGGGAGTCC
GCCTCAGGGATCGTGGAGTTCTGGGTAGATGGGAAGCCCAGGGTGAGGAAGAGTCTGAAG
AAGGGATACACTGTGGGGGCAGAAGCAAGCATCATCTTGGGGCAGGAGCAGGATTCCTTC
GGTGGGAACTTTGAAGGAAGCCAGTCCCTAGTGGGAGACATTGGAAATGTGAACATGTGG
GACTTTGTGCTGTCACCAGATGAGATTAACACCATCTATCTTGGCGGGCCCTTCAGTCCT
AATGTCCTGAACTGGCGGGCACTGAAGTATGAAGTGCAAGGCGAAGTGTTCACCAAACCC
CAGCTGTGGCCCTGA

# Drug_Target_1_General_Function:
Involved in host defense response

# Drug_Target_1_General_References:
10368284	Thompson D, Pepys MB, Wood SP: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure. 1999 Feb 15;7(2):169-77.
2997165	Lei KJ, Liu T, Zon G, Soravia E, Liu TY, Goldman ND: Genomic DNA sequence for human C-reactive protein. J Biol Chem. 1985 Oct 25;260(24):13377-83.
3840479	Woo P, Korenberg JR, Whitehead AS: Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem. 1985 Oct 25;260(24):13384-8.
403526	Osmand AP, Gerwurz H, Friedenson B: Partial amino-acid sequences of human and rabbit C-reactive proteins: homology with immunoglobulins and histocompatibility antigens. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1214-8.
6685157	Tucci A, Goldberger G, Whitehead AS, Kay RM, Woods DE, Colten HR: Biosynthesis and postsynthetic processing of human C-reactive protein. J Immunol. 1983 Nov;131(5):2416-9.
6857266	Whitehead AS, Bruns GA, Markham AF, Colten HR, Woods DE: Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science. 1983 Jul 1;221(4605):69-71.
762075	Oliveira EB, Gotschlich C, Liu TY: Primary structure of human C-reactive protein. J Biol Chem. 1979 Jan 25;254(2):489-502.
7881902	Srinivasan N, White HE, Emsley J, Wood SP, Pepys MB, Blundell TL: Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure. 1994 Nov 15;2(11):1017-27.
8599761	Shrive AK, Cheetham GM, Holden D, Myles DA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ: Three dimensional structure of human C-reactive protein. Nat Struct Biol. 1996 Apr;3(4):346-54.

# Drug_Target_1_HGNC_ID:
HGNC:2367

# Drug_Target_1_HPRD_ID:
00422

# Drug_Target_1_ID:
1017

# Drug_Target_1_Locus:
1q21-q23

# Drug_Target_1_Molecular_Weight:
25039

# Drug_Target_1_Name:
C-reactive protein

# Drug_Target_1_Number_of_Residues:
224

# Drug_Target_1_PDB_ID:
1LJ7

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00354	Pentaxin

# Drug_Target_1_Protein_Sequence:
>C-reactive protein precursor [Contains: C-reactive protein(1-205)]
MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTE
LSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWES
ASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMW
DFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-18

# Drug_Target_1_Specific_Function:
Displays several functions associated with host defense:it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells

# Drug_Target_1_SwissProt_ID:
P02741

# Drug_Target_1_SwissProt_Name:
CRP_HUMAN

# Drug_Target_1_Synonyms:
C-reactive protein precursor

# Drug_Target_1_Theoretical_pI:
5.32

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
ELSPBP1

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6981

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
Not Available

# Drug_Target_2_Name:
Epididymal sperm-binding protein 1

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q96BH3

# Drug_Target_2_SwissProt_Name:
ESPB1_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
Not Available

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
BA000033

# Drug_Target_3_GenBank_ID_Protein:
21205516

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
hlgB

# Drug_Target_3_Gene_Sequence:
>978 bp
ATGAAAATGAATAAATTAGTCAAATCATCCGTTGCTACATCTATGGCATTATTATTACTT
TCTGGTACTGCTAATGCTGAAGGTAAAATAACACCAGTCAGCGTAAAAAAAGTCGATGAC
AAAGTTACTTTATACAAAACAACAGCCACAGCAGATTCTGATAAATTTAAAATTTCACAG
ATTTTAACATTTAATTTCATCAAAGATAAAAGTTATGATAAAGATACTTTAGTACTTAAA
GCTACTGGGAATATTAACTCAGGCTTTGTGAAACCTAATCCTAATGACTATGACTTTTCA
AAATTATATTGGGGAGCTAAATACAATGTATCTATAAGCTCACAATCTAATGATTCAGTA
AACGTCGTTGATTATGCACCAAAAAATCAAAATGAAGAGTTTCAAGTTCAAAATACTTTA
GGCTATACATTTGGTGGTGACATTAGTATCTCTAATGGTTTATCTGGTGGACTTAATGGA
AATACAGCTTTTTCTGAAACAATTAATTATAAACAAGAAAGTTACAGAACAACATTAAGT
CGCAACACAAATTATAAAAATGTTGGCTGGGGAGTTGAAGCACATAAAATTATGAATAAT
GGTTGGGGACCTTATGGACGAGATAGCTTCCACCCAACATATGGTAATGAACTCTTCTTA
GCTGGCAGACAAAGCAGTGCATACGCTGGCCAAAACTTCATAGCGCAACACCAAATGCCA
TTATTATCTAGAAGTAACTTCAATCCAGAATTTTTAAGCGTACTATCACACAGACAAGAT
GGCGCTAAAAAATCTAAAATTACAGTAACTTATCAACGTGAAATGGATTTATACCAAATT
CGTTGGAATGGCTTCTACTGGGCAGGCGCAAATTATAAAAACTTTAAAACTAGAACATTT
AAATCAACATATGAAATTGATTGGGAAAATCACAAAGTGAAATTGTTAGATACAAAAGAA
ACTGAAAACAATAAATAG

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3577

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
36711

# Drug_Target_3_Name:
Gamma-hemolysin component B

# Drug_Target_3_Number_of_Residues:
325

# Drug_Target_3_PDB_ID:
3LKF

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF07968	Leukocidin

# Drug_Target_3_Protein_Sequence:
>Gamma-hemolysin component B precursor
MKMNKLVKSSVATSMALLLLSGTANAEGKITPVSVKKVDDKVTLYKTTATADSDKFKISQ
ILTFNFIKDKSYDKDTLVLKATGNINSGFVKPNPNDYDFSKLYWGAKYNVSISSQSNDSV
NVVDYAPKNQNEEFQVQNTLGYTFGGDISISNGLSGGLNGNTAFSETINYKQESYRTTLS
RNTNYKNVGWGVEAHKIMNNGWGPYGRDSFHPTYGNELFLAGRQSSAYAGQNFIAQHQMP
LLSRSNFNPEFLSVLSHRQDGAKKSKITVTYQREMDLYQIRWNGFYWAGANYKNFKTRTF
KSTYEIDWENHKVKLLDTKETENNK

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-25

# Drug_Target_3_Specific_Function:
Toxin that seems to act by forming pores in the membrane of the cell. Has a hemolytic and a leucotoxic activity

# Drug_Target_3_SwissProt_ID:
P0A076

# Drug_Target_3_SwissProt_Name:
HLGB_STAAW

# Drug_Target_3_Synonyms:
Gamma-hemolysin component B precursor
H-gamma-1
H-gamma-I

# Drug_Target_3_Theoretical_pI:
9.81

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB03945
